Staff Reports
The President’s Plan to Tackle Fentanyl Crisis Misses the Mark. President Biden has once again stumbled over his words, this time calling for a total ban on fentanyl in the United States. The President’s aides were quick to clarify that he was actually just targeting fentanyl-related compounds, but the damage had already been done.
Biden mistakenly urges blanket fentanyl ban after 200K died on his watch. He is as incompetent as they come.https://t.co/IQoNo7H7jo
— Common Sense Is Barely Alive (@bigelow989) November 22, 2023
Biden’s proposal would end common medical uses of fentanyl, which is a Schedule II drug, and move it to the strictly prohibited Schedule I category, reserved for drugs with no allowed medical use. This move could have serious implications for pain management and patient care across the country.
It’s no secret that the fentanyl crisis has devastated countless American families, with approximately 200,000 deaths occurring during Biden’s term. The synthetic opioids responsible for these tragedies have largely been shipped from China, yet President Biden seems more interested in passing the blame to Congress and criticizing Republicans than taking decisive action.
The President’s track record on this issue is concerning, with repeated factual errors and imprecise statements causing further outrage and confusion among the public. It’s clear that Biden either lacks a true understanding of the crisis or simply doesn’t prioritize addressing it effectively.
Biden’s focus on fentanyl comes at a time when he is also seeking funding for international endeavors, such as financing Israel’s war with Hamas and backing Ukraine in its conflict with Russia. The allocation of resources raises questions about the administration’s priorities and whether it’s truly committed to combating the fentanyl epidemic.
While President Biden’s intentions may have been to address the illicit street fentanyl trade, his proposal risks casting a wide net that could impact legitimate medical uses of fentanyl. The complexity of fentanyl-related substances and the challenges in distinguishing them from fentanyl further complicate the issue.
Overall, President Biden’s latest approach to the fentanyl crisis seems more like a political move than a well-thought-out strategy to save American lives. With the ongoing rise in synthetic opioid deaths, the administration’s response falls short of what is needed to truly combat this devastating epidemic.
